Accueil › Cancer du pancréas › Maryland › Baltimore
Essais cliniques pour Cancer du pancréas à Baltimore, MD
31 études pour Cancer du pancréas recherchent des participants dans et autour de Baltimore (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 2
- Johns Hopkins University, Baltimore
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
Recrutement en coursPhase 3
- Johns Hopkins University, Baltimore
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Recrutement en coursPhase 2/3
- JHU Oncology Central Kit Services, Baltimore
- Johns Hopkins Hospital, Baltimore
- Oncology Investigational Drug Service (IDS), Baltimore
- et 1 autres
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Recrutement en coursPhase 3
- Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins & Sibley Memorial Hospital, Baltimore
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Recrutement en coursPhase 3
- University of Maryland School - Division of Hematology/Oncology, Baltimore
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Recrutement en coursPhase 1/2
- The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
Recrutement en coursÉtude observationnelle
- The Johns Hopkins University School of Medicine, Baltimore
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Recrutement en coursPhase 1
- Johns Hopkins, Baltimore
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Recrutement en coursPhase 2
- Johns Hopkins Hospital, Baltimore
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
Recrutement en coursÉtude observationnelle
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors
Recrutement en cours
- Johns Hopkins Hospital, Baltimore
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Recrutement en coursPhase 2
- Johns Hopkins University, Baltimore
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Recrutement en coursPhase 3
- Sinai Hospital of Baltimore, Baltimore
Pancreatic Cancer Registry: For Any Person With a Personal or Family History
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Johns Hopkins Hospital, Baltimore
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
Recrutement en coursPhase 1
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
EXoPERT EMERALD Clinical Study
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- John Hopkins University, Baltimore
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer
Recrutement en coursPhase 1Volontaires sains bienvenus
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Recrutement en coursPhase 1
- Johns Hopkins University, Baltimore
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Recrutement en coursPhase 1/2
- Johns Hopkins Hospital, Baltimore
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Recrutement en coursPhase 3
- Sinai Hospital of Baltimore, Baltimore
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Recrutement en coursPhase 1/2
- Johns Hopkins University, Baltimore
NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
Recrutement en coursPhase 2
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Recrutement en coursPhase 1/2
- Johns Hopkins University, Baltimore
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
Recrutement en coursÉtude observationnelle
- The Johns Hopkins Hospital, Baltimore
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Recrutement en coursPhase 2
- Ohio State University-Telemedicine, Baltimore
Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
Recrutement en coursPhase 1/2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · à 8 mi
The Cancer of the Pancreas Screening-5 CAPS5)Study
Recrutement en coursPhase 3
- Johns Hopkins Hospital, Baltimore
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
Recrutement en coursÉtude observationnelle
- The Johns Hopkins Hospital, Baltimore
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Recrutement en coursPhase 1/2
- Johns Hopkins, Baltimore
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Recrutement en coursÉtude observationnelle
- Johns Hopkins Hospital, Baltimore
Essais pour Cancer du pancréas dans d'autres villes
- Houston, TX61 études
- New York City, NY60 études
- Boston, MA43 études
- Nashville, TN39 études
- Los Angeles, CA35 études
- St. Louis, MO33 études
- Arlington, VA33 études
- San Antonio, TX31 études
- Philadelphia, PA26 études
- Tampa, FL26 études
- Durham, NC24 études
- San Diego, CA24 études
Autres études à Baltimore
- Cancer du poumon non à petites cellules60 études
- Cancer du sein47 études
- Cancer de la prostate43 études
- Cancer du poumon40 études
- Cancer (tous types)37 études
- Cancer colorectal31 études
- Cancer métastatique28 études
- Obésité26 études
- Cancer de la vessie24 études
- Insuffisance cardiaque24 études
- Cancer de l'ovaire22 études
- Accident vasculaire cérébral21 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.